PATRICK G ENRIGHT
CIK 1253886 · last filed 2026-05-26
PATRICK G ENRIGHT is a corporate insider who has filed 149 SEC Form 4 insider transactions across 17 companies since 2008. The most recent filing, for VERA, was dated May 26, 2026. Across all open-market trades the lifetime net is −$89.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $925.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$925.70M
17
149
-$89.38M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERA | Director | 3,602,475 | $34.26 | $123.42M | $32.53M | 11 | 2026-05-26 |
| MANE | Director | 2,407,752 | $96.07 | $231.31M | $18.27M | 1 | 2026-02-05 |
| JAZZ | Director | 21,379 | $230.56 | $4.93M | -$228.70M | 64 | 2026-01-08 |
| ZBIO | Director | 1,844,659 | $19.80 | $36.52M | $9.73M | 3 | 2025-10-14 |
| BIOA | Director | 1,310,589 | $18.04 | $23.64M | $7.20M | 2 | 2025-06-09 |
| Aptinyx Inc. (APTX) Delisted | Director | 3,451,746 | $0.06 | $210.6K | $3.19M | 14 | 2022-05-31 |
| Sierra Oncology, Inc. (SRRA) Delisted | 10%+ Owner | 5,611 | $54.99 | $308.5K | $0 | 1 | 2022-04-29 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 3,918,691 | $2.57 | $10.07M | $12.60M | 1 | 2020-10-22 |
| COLL | Director | 0 | $34.64 | $0 | $1.92M | 11 | 2020-10-14 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,007,225 | $4.00 | $8.03M | $40.00M | 1 | 2020-07-28 |
| 89bio, Inc. (ETNB) Delisted | 10%+ Owner | 2,600,877 | $14.84 | $38.60M | $48.80M | 2 | 2020-07-14 |
| Molecular Templates, Inc. (MTEM) Delisted | 10%+ Owner | 4,198,535 | $0.00 | $420 | $29.98M | 1 | 2019-11-27 |
| Axonics, Inc. (AXNX) Delisted | 10%+ Owner | 2,933,333 | $70.98 | $208.21M | $24.00M | 1 | 2018-11-02 |
| KALA | 10%+ Owner | 2,055,946 | $2.63 | $5.41M | $12.90M | 1 | 2017-07-27 |
| CORT | Director | 5,993,653 | $82.91 | $496.93M | -$43.10M | 26 | 2017-03-20 |
| Aimmune Therapeutics, Inc. (AIMT) Delisted | Director | 7,467,694 | — | — | $10.45M | 3 | 2016-03-31 |
| ESPR | Director | 1,119,256 | $3.15 | $3.53M | -$69.15M | 6 | 2015-05-18 |
Recent Filings
149 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | VERA | Grant (A) | — | $0 | EDGAR |
| 2026-02-05 | MANE | Mixed | +4,653,873 | $18.27M | EDGAR |
| 2026-01-08 | JAZZ | Other (J) | −5,000 | $0 | EDGAR |
| 2025-12-15 | VERA | Buy (P) | +5,882 | $250.0K | EDGAR |
| 2025-10-14 | ZBIO | Buy (P) | +117,255 | $2.25M | EDGAR |
| 2025-08-11 | JAZZ | Mixed | +1,702 | -$200.8K | EDGAR |
| 2025-06-25 | VERA | Buy (P) | +250,000 | $5.28M | EDGAR |
| 2025-06-12 | ZBIO | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | BIOA | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | VERA | Grant (A) | — | $0 | EDGAR |